RA Capital's return, page-38

Love yr work pga2003. I could only think of two theories - either its going great and big pharma very interested and thus influential, or its going poorly and the Co were just glad for the ipo cash to buy more time until a new strategy could be worked to milk the ip and keep them in employment.

That response would indicate the former.

(And the crap sp movement could reflect either situation for different reasons, so isnt enlightening)